May 20, 2025

Latest posts

[ May 19, 2025 ] SGLT2 Inhibitors May Lower Cardiac Risk from Cancer Therapy Author Summary
[ May 16, 2025 ] Andrographolide Slows Cervical Cancer Growth in CAM-PDX Model Author Summary
[ May 14, 2025 ] Noninvasive Ocular Nanoparticle Delivery: 20-Year Analysis Author Summary
[ May 12, 2025 ] Chest CT and AI Predict Breast Cancer and Lymph Node Spread Author Summary
[ May 9, 2025 ] How a Natural Compound May Slow Osteoarthritis: Insights into Morinda officinalis Polysaccharides Author Summary

CD44 and TNFSF14 Identified as Key Immune Targets in Glioblastoma

CD44 and TNFSF14 Identified as Key Immune Targets in Glioblastoma

CD44 and TNFSF14 Identified as Key Immune Targets in Glioblastoma

Leave a ReplyCancel reply

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH